张娟
+
Gender:Female
Paper Publications
- [1] 张娟. Increased ROCK1 not ROCK2 in circulating leukocytes in rats with myocardial ischemia/reperfusion. Perfusion-UK, 819, 2020.
- [2] 程超. Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion. Exp Ther Med, 2020.
- [3] 程超. MicroRNA-145-5p inhibits hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes by targeting ROCK1. Experimental and Therapeutic medicine, 22, 2021.
- [4] 张娟. Increased ROCK1 not ROCK2 in circulating leukocytes in rats with myocardial ischemia/reperfusion. Perfusion-UK , 2020.
- [5] 张娟. Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion. Exp Ther Med , 2020.
- [6] 张娟. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis. YONSEI MEDICAL JOURNAL, 2016.
- [7] 程超. Increased ROCK1 not ROCK2 in circulating leukocytes in rats with myocardial ischemia/reperfusion. PERFUSION-UK, 35, 819, 2020.
- [8] 程超. Inhibition of Rho-kinase is involved in the therapeutic effects of atorvastatin in heart ischemia/reperfusion. Experimental and Therapeutic medicine, 20, 3147, 2020.
- [9] 程超 , 鹿庆华 and 毕少杰. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Plos One, 14, 2019.
- [10] 张娟. Increased Rho kinase activity in patients with heart ischemia/reperfusion. PERFUSION-UK, 34, 15, 2019.
| TOTAL 10 PIECE 1/1 | FIRSTPREVIOUSNEXTLAST |